PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Kosuke Yoshihara

Niigata University

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 7, 2026 · JOURNAL ARTICLE

Real-world safety and effectiveness of olaparib maintenance after first-relapse platinum-sensitive ovarian cancer in Japan: a multicenter historical cohort (JGOG3026)

Journal of Gynecologic Oncology

Real-world cohort study confirms safety and effectiveness of olaparib maintenance in Japanese patients with platinum-sensitive relapsed ovarian cancer, consistent with trial evidence but without comparative control arm.

Important Confirmatory EvidenceTakayuki Enomoto Yasunori Yoshino Ovarian Cancer Diagnosis and Treatment

Reported

Sample size (mITT1)413

Grade ≥3 adverse events41.6%

Anemia (Grade ≥3)28.8%

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support